Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine and Palonosetron without Dexamethasone for CINV
NCT02970643Unknown
- Start
- Jul 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV). Primary endpoint: Number of Patients With Grade 3 Through Grade 5 Adverse Events That Are Related to Study Drug, Graded According to NCI CTCAE Version 4.0 nausea. Status: unknown.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT02970643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02970643.